Differential Effects of Monoterpenes and Lovastatin on RAS Processing
Open Access
- 1 July 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (29) , 17508-17512
- https://doi.org/10.1074/jbc.270.29.17508
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferationBiochemical Pharmacology, 1994
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993
- Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptidesCell, 1990
- Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.Proceedings of the National Academy of Sciences, 1990
- Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and HumansScience, 1989
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oilCarcinogenesis: Integrative Cancer Research, 1989
- Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesisCarcinogenesis: Integrative Cancer Research, 1988
- Inhibition of DMBA-induced mammary cancer by the monoterpene d-limoneneCarcinogenesis: Integrative Cancer Research, 1984